Use fundamental data analysis to double-check all available reported financial drivers of Agilent Technologies Inc to find out if markets are presently mispricing the company. We found thirty-six available fundamental indicators for Agilent Technologies Inc which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Agilent Technologies Inc fundamentals including its Shares Owned by Institutions, Price to Sales, Net Income, as well as the relationship between Price to Earning and Gross Profit . Given that Agilent Technologies Inc has Price to Book of 4.62 times, we suggest you validate Agilent Technologies Inc prevailing market performance to make sure the company can sustain itself down the road.Use Agilent Technologies to protect against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier. Check odds of Agilent Technologies to be traded at $65.54 in 30 days
Agilent Technologies Inc Valuation Over Time
Agilent Technologies Company SummaryAgilent Technologies competes with Curtiss Wright, Sensata Technologies, FLIR Systems, and AMETEK INC. Its Life Sciences and Applied Markets segment offers liquid chromatography systems and components liquid chromatography mass spectrometry systems gas chromatography systems and components gas chromatography mass spectrometry systems inductively coupled plasma mass spectrometry instruments atomic absorption instruments microwave plasmaatomic emission spectrometry instruments inductively coupled plasma optical emission spectrometry instruments laboratory software and informatics systems laboratory automation and robotic systems dissolution testing vacuum pumps and measurement technologies. Agilent Technologies Incs Diagnostics and Genomics segment offer reagents, instruments, software, and consumables arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. Its Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies and startup, operational, training, and compliance support, as well as asset management and consultation services. Agilent Technologies Inc markets and sells its solutions through direct sales, electronic commerce, resellers, manufacturers representatives, and distributors. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.
Agilent Technologies EBITDA vs Z Score
Agilent Technologies Inc is rated fourth in ebitda category among related companies. It is rated fourth in z score category among related companies . The ratio of EBITDA to Z Score for Agilent Technologies Inc is about 170,000,000
Agilent Technologies Fundamentals
|Better Than Average||Worse Than Average||Compare Agilent Technologies to competition|